UBS Raises PT on Colfax (CFX), Sees Years of Strong Growth
Tweet Send to a FriendGet Alerts CFX Hot Sheet
Price: $49.40 --0%
Rating Summary:
3 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 6
Rating Summary:
3 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 6
Trade CFX Now!
UBS boosted its price target on Buy-rated Colfax Corporation (NYSE: CFX) from $38 to $42 calling in a "compelling long-term growth story."
While the stock is not without risks, UBS views it as among the most attractive multi-year growth stories in the sector.
"We still expect a '12-'16 adj. EPS CAGR of 30%+ (albeit, off a lower '12 base), driven by deleveraging, restructuring cost saving initiatives, conversion of the convertible preferred, and (hopefully) a cyclical recovery. We also see upside from future M&A activity. However, given CFX's outperformance since July, and lower base-year EPS for ’12, CFX is now somewhat more of a "macro bet" than it was in late '11/1H12."
UBS Revised '12/'13 EPS estimates are $1.32/$2.05, respectively.
For an analyst ratings summary and ratings history on Colfax Corporation click here. For more ratings news on Colfax Corporation click here.
Shares of Colfax Corporation closed at $35.29 yesterday, with a 52 week range of $24.43-$37.64.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
While the stock is not without risks, UBS views it as among the most attractive multi-year growth stories in the sector.
"We still expect a '12-'16 adj. EPS CAGR of 30%+ (albeit, off a lower '12 base), driven by deleveraging, restructuring cost saving initiatives, conversion of the convertible preferred, and (hopefully) a cyclical recovery. We also see upside from future M&A activity. However, given CFX's outperformance since July, and lower base-year EPS for ’12, CFX is now somewhat more of a "macro bet" than it was in late '11/1H12."
UBS Revised '12/'13 EPS estimates are $1.32/$2.05, respectively.
For an analyst ratings summary and ratings history on Colfax Corporation click here. For more ratings news on Colfax Corporation click here.
Shares of Colfax Corporation closed at $35.29 yesterday, with a 52 week range of $24.43-$37.64.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UBS Raises PT on Tesoro (TSO)
- UPDATE: BTIG Starts ING U.S (VOYA) at Buy, Shares 'Significantly Undervalued'
- UPDATE: Michael Kors (KORS) Under-Appreciated; Canaccord Genuity Starts at Buy
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst PT ChangeRelated Entities
UBS
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
